--- title: "UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Rating of \"Moderate Buy\" by Brokerages" description: "UnitedHealth Group Incorporated (NYSE:UNH) has received a consensus rating of \"Moderate Buy\" from 24 analysts. The average 1-year price target is $366.52. Recent ratings include Piper Sandler lowering" type: "news" locale: "en" url: "https://longbridge.com/en/news/252975404.md" published_at: "2025-08-14T06:39:28.000Z" --- # UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Rating of "Moderate Buy" by Brokerages > UnitedHealth Group Incorporated (NYSE:UNH) has received a consensus rating of "Moderate Buy" from 24 analysts. The average 1-year price target is $366.52. Recent ratings include Piper Sandler lowering its target from $353 to $317, and KeyCorp reducing its target from $400 to $350. The stock opened at $271.92, with a market cap of $246.27 billion. The company reported $4.08 EPS, missing estimates, and announced a quarterly dividend of $2.21. Insiders have made significant stock transactions recently, with CEO Stephen J. Hemsley purchasing 86,700 shares. Shares of UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) have received a consensus rating of "Moderate Buy" from the twenty-four analysts that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and fifteen have given a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $366.5238. Get **UnitedHealth Group** alerts: - Can HCA Healthcare Revive the Market’s Weakest Sector? Several analysts have recently issued reports on UNH shares. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. KeyCorp dropped their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. **View Our Latest Stock Report on UnitedHealth Group** ## UnitedHealth Group Stock Performance - Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound Shares of UnitedHealth Group stock opened at $271.92 on Thursday. The business has a 50-day moving average of $289.37 and a 200 day moving average of $401.34. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $246.27 billion, a price-to-earnings ratio of 11.78, a price-to-earnings-growth ratio of 1.69 and a beta of 0.43. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $630.73. UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. During the same period last year, the business posted $6.80 EPS. As a group, sell-side analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year. ## UnitedHealth Group Dividend Announcement - Insiders Spent Millions on These 3 Stocks Over the Past 2 Months The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.3%. UnitedHealth Group's dividend payout ratio is presently 38.30%. ## Insiders Place Their Bets In other news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.28% of the company's stock. ## Institutional Inflows and Outflows Several large investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of UnitedHealth Group by 3.3% during the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock valued at $6,624,411,000 after buying an additional 675,075 shares during the last quarter. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after buying an additional 906,365 shares in the last quarter. Finally, Norges Bank acquired a new stake in UnitedHealth Group in the 2nd quarter worth approximately $3,837,207,000. 87.86% of the stock is owned by hedge funds and other institutional investors. ## About UnitedHealth Group (Get Free Report) UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. ## Featured Articles - Five stocks we like better than UnitedHealth Group - How to Short a Stock in 5 Easy Steps - 3 Earnings Reports Give a Snapshot of Consumer Sentiment - Where Do I Find 52-Week Highs and Lows? - Amazon’s Bears Have Raised the White Flag—Get Excited - How to Know Which Cryptocurrency to Buy: A Guide for Investors - Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead? *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in UnitedHealth Group Right Now? Before you consider UnitedHealth Group, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list. While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [UNH.US - Unitedhealth](https://longbridge.com/en/quote/UNH.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 联合健康｜8-K：2025 财年营收 4476 亿美元不及预期 | | [Link](https://longbridge.com/en/news/273832348.md) | | DELL, SPOT, UNH：全球最大的对冲基金正在市场中寻找抄底机会 | 桥水基金（Bridgewater Associates），全球最大的对冲基金，管理资产达 1360 亿美元，在 2025 年第四季度对表现不佳的股票进行了重大投资，包括戴尔（DELL）、Spotify（SPOT）和联合健康（UnitedHe | [Link](https://longbridge.com/en/news/276384705.md) | | 特朗普暗示违法征收的关税不退了，美财长称今年关税收入将 “基本保持不变” | 美国总统特朗普暗示不会退还被最高法院裁定违法的关税，预计 2026 年关税收入将保持不变。特朗普计划签署行政令，对全球商品加征 10% 进口关税，取代被推翻的关税。财长贝森特表示，政府将利用替代法律权力维持关税收入，强调国家安全和财政收入不 | [Link](https://longbridge.com/en/news/276494362.md) | | 美财政部让步，拟修订主权财富基金税收提案，此前遭私募业警告 | 美国财政部正就一项针对主权财富基金和公共养老基金征税方式进行全面改革的提案作出让步。相关提案此前由美国国税局提出，拟更新税法第 892 条，将这些基金持有的多数美国债务投资归为商业活动，这将令其面临被征税的风险。此前，私募信贷和私募股权公司 | [Link](https://longbridge.com/en/news/276491732.md) | | 都想学英伟达 “芯片换融资”，谷歌和 AMD 都要扶持 “AI 云” | 谷歌正试图复制英伟达的成功路径，利用金融实力构建芯片生态系统。公司正洽谈向 “新型云” 公司 Fluidstack 注资约 1 亿美元，并为 Hut 8 等转型矿企提供项目融资支持，以换取 TPU 芯片的采用。AMD 则更为激进，为初创公司 | [Link](https://longbridge.com/en/news/276502552.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.